TEF

3.676

+3.26%↑

KPN

4.731

+1.5%↑

TELIA1.FI

4.32

+2.13%↑

ELISA.FI

42.72

+0.8%↑

DEC

18.95

-2.07%↓

TEF

3.676

+3.26%↑

KPN

4.731

+1.5%↑

TELIA1.FI

4.32

+2.13%↑

ELISA.FI

42.72

+0.8%↑

DEC

18.95

-2.07%↓

TEF

3.676

+3.26%↑

KPN

4.731

+1.5%↑

TELIA1.FI

4.32

+2.13%↑

ELISA.FI

42.72

+0.8%↑

DEC

18.95

-2.07%↓

TEF

3.676

+3.26%↑

KPN

4.731

+1.5%↑

TELIA1.FI

4.32

+2.13%↑

ELISA.FI

42.72

+0.8%↑

DEC

18.95

-2.07%↓

TEF

3.676

+3.26%↑

KPN

4.731

+1.5%↑

TELIA1.FI

4.32

+2.13%↑

ELISA.FI

42.72

+0.8%↑

DEC

18.95

-2.07%↓

Search

Stroeer SE & Co KGaA

Închisă

SectorServicii de comunicare

29.75 -0.34

Rezumat

Modificarea prețului

24h

Curent

Minim

29.45

Maxim

30.55

Indicatori cheie

By Trading Economics

Venit

-2.4M

30M

Vânzări

-13M

492M

P/E

Medie Sector

15.769

50.178

EPS

0.441

Randament dividend

6.68

Marjă de profit

6.093

Angajați

11,858

EBITDA

-2.7M

135M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+47.63% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

6.68%

4.43%

Următoarele câștiguri

26 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-447M

2.1B

Deschiderea anterioară

30.09

Închiderea anterioară

29.75

Sentimentul știrilor

By Acuity

38%

62%

37 / 139 Clasament în Communication services

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Stroeer SE & Co KGaA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mar. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar. 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar. 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar. 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar. 2026, 22:40 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar. 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar. 2026, 22:18 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar. 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar. 2026, 21:10 UTC

Evenimente importante

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk
Câștiguri
Evenimente importante

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

Stroeer SE & Co KGaA Așteptări

Obiectiv de preț

By TipRanks

47.63% sus

Prognoză pe 12 luni

Medie 44.14 EUR  47.63%

Maxim 60 EUR

Minim 35 EUR

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruStroeer SE & Co KGaA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

4

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 52.4Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

37 / 139 Clasament în Servicii de comunicare

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Stroeer SE & Co KGaA

Ströer SE & Co. KGaA provides out-of-home (OOH) media and online advertising solutions in Germany and internationally. It operates through three segments: Out-of-Home Media, Digital & Dialog Media, and Data As A Service (DaaS) & E-Commerce. The company offers various OOH advertising media services, such as traditional posters media and advertisements at bus and tram shelters and on public transport; and digital advertising services. It also operates t-online.de, which publishes news, analyses, reports and interviews through digital channels; information services for digital natives through special interest portals, such as giga.de, kino.de, desired, familie.de, spieletipps.de, and SpielAffe.de; and call centers focus on customer experience and sales for telecommunications, energy, retail, financial services, and medica sectors. In addition, the company provides Statista, a platform for business data as a service that offers market and consumer data, and bundles statistical data; and asambeauty, a streaming-based live shopping beauty platform. Ströer SE & Co. KGaA was incorporated in 2016 and is based in Cologne, Germany.
help-icon Live chat